Katelyn Falco, PHARMACIST in Norwich, CT - Pharmacist

Katelyn Falco, PHARMACIST is a Pharmacist based in Norwich, Connecticut. Katelyn Falco is licensed to practice in Connecticut (license number PCT.0016276) and her current practice location is 42 Town St Ste 100, Norwich, Connecticut. She can be reached at her office (for appointments etc.) via phone at (860) 887-1615.

NPI number for Katelyn Falco is 1306524236 and her current mailing address is 42 Town St Ste 100, Norwich, Connecticut. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1306524236.

Contact Information

	Katelyn Falco, PHARMACIST
	42 Town St Ste 100, Norwich, CT 06360-2342
	(860) 887-1615
	Not Available

Healthcare Provider's Profile

Full Name	Katelyn Falco
Gender	Female
Speciality	Pharmacist
Location	42 Town St Ste 100, Norwich, Connecticut
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1306524236
Provider Enumeration Date: 07/10/2023
Last Update Date: 07/10/2023

Medical Identifiers

Medical identifiers for Katelyn Falco such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1306524236	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
183500000X	Pharmacist	PCT.0016276 (Connecticut)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Katelyn Falco is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Katelyn Falco, PHARMACIST 42 Town St Ste 100, Norwich, CT 06360-2342 Ph: (860) 887-1615	Katelyn Falco, PHARMACIST 42 Town St Ste 100, Norwich, CT 06360-2342 Ph: (860) 887-1615

News Archive

Shire's INTUNIV for treating ADHD now available in the U.S.

Shire plc, the global specialty biopharmaceutical company, today announced the availability of INTUNIV(TM) (guanfacine) Extended Release Tablets in pharmacies across the United States for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children and adolescents ages 6 to 17.

Birth mode may have acute effects on neurodevelopment, study suggests

Cesarean-born mice show altered patterns of cell death across the brain, exhibiting greater nerve cell death than vaginally delivered mice in at least one brain area, a finding by Georgia State University researchers that suggests birth mode may have acute effects on human neurodevelopment that may lead to long-lasting changes in the brain and behavior.

FDA undecided on safety guidelines for hydroquinone use

According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the US market for physician-dispensed cosmeceutical pigment control products will experience considerable growth in sales over the next five years. MRG's US Markets for Physician-Dispensed Cosmeceuticals 2009 report finds, however, that product safety issues involving hydroquinone, the active ingredient in many pigment control products, have led the Food and Drug Administration (FDA) to second guess the use of the compound in such products.

Meta-analysis shows that XRCC1 Arg399Gln polymorphism may be a biomarker of glioma susceptibility

DNA damage is an important mechanism of glioma. X-ray cross-complementing group 1 (XRCC1) is a DNA repair gene that participates in the base excision repair pathway. To date, many studies have been performed to investigate the association between the XRCC1 polymorphisms and risk of cancers such as breast cancer, and gastroesophageal cancer, but the number of studies that focused on glioma is relatively small.

Potent antiplatelet drug not superior to standard of care in reducing heart attack risk during angioplasty

The use of the more potent antiplatelet medication ticagrelor was not superior to clopidogrel in the reduction of the rate of heart attack or severe complications among people undergoing an elective procedure to open a blocked artery, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2020.

Pharmacist in Norwich, CT

Basil Patel, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 42 Town St, Norwich, CT 06360 Phone: 860-887-1615
Seul Kim, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 399 W Main St, Norwich, CT 06360 Phone: 860-885-0389
Md Helal Uddin Biswas, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 399 W Main St, Norwich, CT 06360 Phone: 860-885-0389
Jacinta Jewell, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 399 W Main St, Norwich, CT 06360 Phone: 860-885-0389
Mrs. Mary L Yuen, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 399 W Main St, Norwich, CT 06360 Phone: 860-885-0389
Dr. Victoria J Lambert, PHARMD, CACP Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 111 Salem Tpke, Norwich, CT 06360 Phone: 860-892-2711 Fax: 860-859-4488
Garrett Davis, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 220 Salem Tpke, Norwich, CT 06360 Phone: 860-889-7530

Katelyn Falco, PHARMACIST - Pharmacist in Norwich, CT